FDA Coronavirus (COVID-19) Update: June 26th, 2020
June 26, 2020
Silver Spring, MD – The U.S. Food and Drug Administration continues to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
A new FDA Voices, titled Partnering with the European Union and Global Regulators on COVID-19, explains how the FDA and the European Union, including the latter’s European Medicines Agency, have long leveraged each other’s expertise and experience to promote the safety, effectiveness, and quality of medical products to advance the health of our respective citizens.
Coronavirus
FDA Coronavirus (COVID-19) Update: June 9th, 2020
June 9, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today continued to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
On June 6th, 2020, in response to public health and safety concerns about the appropriateness of decontaminating certain respirators, the FDA issued certain Emergency Use Authorizations (EUAs) to revise which respirators the decontamination systems are authorized to decontaminate.
Coronavirus
FDA Coronavirus (COVID-19) Update: May 12th, 2020
May 12, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) continues to take action in the ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued an Emergency Use Authorization (EUA) for emergency use of the Fresenius Propoven 2% Emulsion to maintain sedation via continuous infusion in patients older than 16 who require mechanical ventilation in an ICU during the COVID-19 Coronavirus public health emergency.
Coronavirus
Top 10 moments from President Donald Trump’s Virtual Town Hall
May 4, 2020
Washington, D.C. – With the Lincoln Memorial as a backdrop, President Donald rump took questions from Americans for 2 hours last night as part of a Fox News Virtual Town Hall.
“We never had a more beautiful set than this,” the President said.
Together, Americans are beating this Coronavirus. After months of slowing the spread of disease, our country is prepared for the next stage in this fight.
President Donald Trump participates in a FOX News Channel virtual town hall live from the Lincoln Memorial. (White House)
FDA Coronavirus (COVID-19) Update: May 2nd, 2020
May 2, 2020
Silver Spring, MD – The U.S. Food and Drug Administration continues to take action in the ongoing response effort to the COVID-19 Coronavirus pandemic:
Friday, the FDA issued an Emergency Use Authorization (EUA) for the investigational antiviral drug remdesivir.
Coronavirus
President Donald Trump’s remarks about Remdesivir announcement
May 1, 2020
Washington, D.C. – PRESIDENT Donald Trump: Well, thank you very much. And welcome to Dan O’Day, CEO of Gilead. You know what that is because it’s been in the news and the company has been in the news, and it’s a great American company that’s done incredible work on HIV and hepatitis C. And I hear that — that’s what’s happening with hepatitis is the great — a great medical story. Really, a great medical story. I’ve been hearing about that. It’s fantastic, Dan.
I’m pleased to announce that Gilead now has an EUA from the FDA for remdesivir. And you know what that is because that’s been the hot thing also in the papers and in the media for the last little while.
U.S. President Donald J. Trump
New Personal Active UVC Air Sterilizer Will Combat COVID-19
May 1, 2020
Algonquin, IL – With the COVID-19 Coronavirus pandemic plaguing the U.S. and people around the world, Cair Products (www.cairproducts.com) announces the development of its new Personal Active UVC Air Sterilizer is in its final stages of testing and certification. The product will be available within 45 days of the release with a “patent pending” status.
With this unit, a patent-pending active sterilization system focuses on the individual user and sterilizing the air the user breathes and exhales.
Coronavirus.
FDA Coronavirus (COVID-19) Update: May 1st, 2020
May 1, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has continued to take action in the ongoing response effort to the COVID-19 Coronavirus pandemic:
Thursday, the FDA included, under the ventilator emergency use authorization (EUA), a ventilator developed by the National Aeronautics and Space Administration (NASA), which is tailored to treat patients with COVID-19 Coronavirus.
Coronavirus
FDA Coronavirus (COVID-19) Update: April 30th, 2020
April 30, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Wednesday, the FDA issued a Consumer Update, Tips on Good Nutrition and Using the Updated Nutrition Facts Label During the Coronavirus Pandemic.
Coronavirus
With Excess National Supply, Exchanges Will Allow U.S. Hospitals to Continue Meeting Ventilator Demand
April 25, 2020
Washington, D.C. – During the COVID-19 Coronavirus pandemic, the Federal Government has worked tirelessly to “bend the curve” and prevent healthcare utilization from exceeding the healthcare system’s capacity. Given ventilators’ life-saving role, it is important that demand stay below supply so that no person who is in need of a ventilator is denied one.
Federal policy has achieved this objective so far, and the Trump Administration recently announced the voluntary Dynamic Ventilator Reserve to ensure that patients everywhere can continue accessing ventilators.
President Donald Trump giving update to the COVID-19 crisis. (White House)
